Ted,
Here is a response:
"As far as yesterday's press release, I will leave the board with these questions to answer:
If ABT, who has a market cap of over $80 billion dollars, didn't want to spend/risk money on getting approval for their test, do you believe that clinical labs will individually fork over money to do so?"
Maybe it wasn't an issue of money for Abbott. Maybe they had other issues with selling the Division, keeping certification for their analyzers, internal management problems, etc. Maybe they wanted to keep the license with Biocurex and will be happy to sell our product in the future.
"If you were the head of one of these labs wouldn't you ask Dr. Moro to get the test approved first and then to come back once he does?"
Some might. But since there is a cost to the institution for the license agreement, some my just negotiate this as part of their cost.
"If you answered no to these two questions, then you should ask yourself 2 other questions:
1)Does Dr. Moro truly believe that he can convince these labs to do so?"
Probably not all of them but some of them. Some may be set up as only researchers and not as seekers of approvals.
"2)If he doesn't truly believe these labs will buy into his proposition, why put out such a press release?"
He does believe!!!
